MedTech1.com - Organogenesis Inc.">

Other Body1 Health Sites:				Empower your Life™

Main Page

MedTech News

Tech & Innovation

Living With a Device

Education Center

Diagnostic Tests

Conditions

Procedures

Women's Health

Companies

Online Resources

Video Library

MedTech Hero™
Drs. Sherif Emil and Nabil Fanous:
Pioneering Surgical Techniques to Minimize Scars.
About Heroes

Join the Discussion in Our Forums

Community

MedTech1 Forums

Advocacy Center

Become an Advocate

Contact Congress

Find a Patient Group

Video Library

Bookmark Us


	Search the Body1 Network

March 17, 2010

RESEARCH CENTER: Search Companies

Organogenesis Inc.">

Company Description:
Organogenesis Inc. is the only tissue-engineering company to have developed and gained FDA PMA marketing approval for a mass-produced product containing living human cells. The Company's lead product, Apligraf – a cellular, bi-layered skin substitute – is FDA approved for the treatment of venous leg ulcers and diabetic foot ulcers; Novartis Pharma AG has global Apligraf marketing rights. Organogenesis is leveraging its FortaFlex™ bioengineered collagen matrix technology into a family of products, and has recently achieved marketing clearance for its FortaPerm™ surgical sling and PuraPly™ wound dressing. The Organogenesis research pipeline includes the Vitrix™ living dermal replacement, a coronary vascular graft and a liver assist device.

Return to Search Results
Search for Another Company

Home

About Us

Press

Jobs

Advertise With Us

Disclaimer: The information provided within this website is for educational purposes only and is not a substitute for consultation with your physician or healthcare provider. The opinions expressed herein are not necessarily those of the Owners and Sponsors of this site. By using this site you agree to indemnify, and hold the Owners and Sponsors harmless, from any disputes arising from content posted here-in.
See our Terms of Service, our Privacy Policy, our Advertising Policy and our Editorial Policy.